Ranibizumab Monoclonal Antibody from Germany
Ranibizumab is an affinity-matured humanized monoclonal antibody fragment used to treat wet age-related macular degeneration. As an unmixed bulk product not in measured doses or retail packaging, it is classified under tariff item 3002.13.00, with antibody fragments explicitly covered by chapter note 2.
Duty Rate — Germany → Canada
0%
Import Tips
• Confirm the product is an antibody fragment and document this in the import paperwork to support classification
• Ensure the product is unmixed and free of any added stabilizers
• Verify whether a Canadian establishment licence is required for the receiving facility